Biomea Fusion Statistics
Total Valuation
Biomea Fusion has a market cap or net worth of $138.09 million. The enterprise value is $84.59 million.
Important Dates
The next estimated earnings date is Monday, May 4, 2026, after market close.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomea Fusion has 72.30 million shares outstanding. The number of shares has increased by 44.65% in one year.
| Current Share Class | 72.30M |
| Shares Outstanding | 72.30M |
| Shares Change (YoY) | +44.65% |
| Shares Change (QoQ) | +19.55% |
| Owned by Insiders (%) | 6.71% |
| Owned by Institutions (%) | 37.99% |
| Float | 67.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.02 |
| P/TBV Ratio | 4.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.23, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.23 |
| Quick Ratio | 5.03 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -152.35% and return on invested capital (ROIC) is -111.09%.
| Return on Equity (ROE) | -152.35% |
| Return on Assets (ROA) | -73.38% |
| Return on Invested Capital (ROIC) | -111.09% |
| Return on Capital Employed (ROCE) | -171.28% |
| Weighted Average Cost of Capital (WACC) | 2.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.51M |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.02% in the last 52 weeks. The beta is -0.27, so Biomea Fusion's price volatility has been lower than the market average.
| Beta (5Y) | -0.27 |
| 52-Week Price Change | +13.02% |
| 50-Day Moving Average | 1.47 |
| 200-Day Moving Average | 1.54 |
| Relative Strength Index (RSI) | 59.32 |
| Average Volume (20 Days) | 2,073,619 |
Short Selling Information
The latest short interest is 12.77 million, so 17.67% of the outstanding shares have been sold short.
| Short Interest | 12.77M |
| Short Previous Month | 12.15M |
| Short % of Shares Out | 17.67% |
| Short % of Float | 18.94% |
| Short Ratio (days to cover) | 9.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -81.31M |
| Pretax Income | -61.80M |
| Net Income | -61.80M |
| EBITDA | -79.90M |
| EBIT | -81.31M |
| Earnings Per Share (EPS) | -$1.18 |
Full Income Statement Balance Sheet
The company has $55.81 million in cash and $1.59 million in debt, with a net cash position of $54.22 million or $0.75 per share.
| Cash & Cash Equivalents | 55.81M |
| Total Debt | 1.59M |
| Net Cash | 54.22M |
| Net Cash Per Share | $0.75 |
| Equity (Book Value) | 29.55M |
| Book Value Per Share | 0.41 |
| Working Capital | 46.95M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -70.37M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.41M |
| Net Borrowing | n/a |
| Free Cash Flow | -70.37M |
| FCF Per Share | -$0.97 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biomea Fusion does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -44.65% |
| Shareholder Yield | -44.65% |
| Earnings Yield | -44.52% |
| FCF Yield | -50.69% |
Analyst Forecast
The average price target for Biomea Fusion is $9.83, which is 414.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.83 |
| Price Target Difference | 414.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -38.75% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |